Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An RNA-directed DNA polymerase was found to be associated with intracytoplasmic A-particles from
DBA
/2 mouse leukemia cells. The enzyme activity was detected after disrupting the purified particles with 2 M NaCl-20 mM dithiothreitol. The presence of a divalent cation and all four deoxyribonucleoside triphosphates was essential for this enzyme activity. The enzyme had a clear preference for Mg2+ over Mn2+. Cesium sulfate isopycnic gradient centrifugation of the DNA product synthesized in the actinomycin D-containing reaction revealed the presence of DNA-RNA hybrid. Furthermore, the purified DNA product was found to hybridize with RNA isolated from A-particles. These observations strongly indicate that the endogenous A-particle RNA serves as the template for the
DNA polymerase
.
...
PMID:Characterization of an RNA-directed DNA polymerase found in association with murine intracytoplasmic A-particles. 6 24
A total of 18 compounds consisting of 7 alphatic and 7 aromatic bis(guanylhydrazones), p-quinone-bis(guanylhydrazone), one monoguanylhydrazone, one diamidine and one diguanidine were studied spectrophotometrically to determine their ability to interact with native calf-thymus DNA and the possible correlation of binding with biological activity. In each case, the ability of a compound to bind to DNA correlate with its ability to inhibit the activity of
DNA-dependent DNA polymerase
(
EC 2.7.7.7
) extracted from mouse leukemia L1210 cells. For example, all the aromatic bis-guanylhydrazones and diamidine (hydroxystilbamidine), which were good inhibitors of the enzyme activity, showed a biphasic interaction with DNA. All the aliphatic compounds displayed no detectable interaction with DNA in the Tris buffer used, and were also poor inhibitors of the polymerase activity. Interaction of decamethylene diguanide (Synthalin with DNA could not be determined because the compound does not absorb light in the UV-VIS region. However, in similarity with other aliphatic compounds, this agent was a poor inhibitor of
DNA polymerase
reduction. The p-quinone-bis(guanyl-hydrazone) and p-phenylbenzaldehyde-monoguanylhydrazone showed only a monophasic interaction with DNA and caused an intermediate inhibition of the enzyme activity. When tested for possible anti-leukemic activity against i.p. L1210 leukemia in syngeneic
DBA
/2J mice, all the aromatic bis-guanylhydrazones as well as hydroxystilbamidine caused prolongation of survival of tumor-bearing mice. Among the aliphatic bisguanylhydrazones, all of which showed no binding to DNA and caused at the most only a very slight inhibition of
DNA polymerase
, only methylglyoxal-bis(guanylhydrazone) (CH3--G) had antileukemic activity. Synthalin also inhibited leukemia growth. Evidences presented indicate that the mechanisms of action of aliphatic and aromatic bisguanylhydrazones may be quite different. Furthermore, the ability to bind to DNA may be a useful criterion to predict the antileukemic activity of aromatic guanylhydrazones and possibly other aromatic-bis-cationic compounds, but not that of aliphatic congeners.
...
PMID:Studies on the structure--activity relationship among aliphatic and aromatic bisguanylhydrazones and some related compounds. 83 65
Characteristics of Drug-Resistant Cell Sublines L5178Y: We isolated aclarubicin (ACR)-, adriamycin (ADM)-, bleomycin (BLM-, and macromomycin (MCR)-resistant (r) cell sublines. The BLMr cell line did not show cross-resistance to other drugs. The ACRr and ADMr cell lines displayed cross-resistance to other anthracyclines. The drug-resistance of these cell lines was due to changes in membrane transport. All four resistant cell lines showed higher activity of membrane alkaline phosphodiesterase (APD) than the parental cells. The APD of the BLMr scell line differed from that of the parental line in molecular size. 2-Crotonyloxymethyl-4, 5, 6-trihydroxycyclohex-2-enone: We isolated an inhibitor of APD from a Streptomyces species. This substance inhibited the drug-resistant cell lines of L5178Y more markedly than the parental line in culture and showed synergistic effects with ACR against the ACRr cell line. It was an SH-inhibitor, and prevented
DNA polymerase alpha
and some mitotic processes. Transplantability of Drug-Resistant L5178Y Cells:
DBA
/2 mice, the syngeneic host, exhibited more resistance to ip transplantation of drug-resistant cell lines than parental cells. The animals showed the strongest resistance to the ACRr cell line. Treatment with cyclophosphamide markedly reversed the host resistance, suggesting that the immune mechanism was involved in the resistance. The ACRr cells were sensitive to NK cells, but the parental cells were not. Injection with anti-asialo GM1 markedly decreased host resistance. The results suggested that NK cells were involved in the transplantation resistance of mice to the ACRr cells. 230-Kilodalton Membrane Protein of ACRr Cells Identified by Monoclonal Antibody: We prepared monoclonal antibodies to the ACRr cells, and found that a monoclonal antibody, designated SC438, specifically agglutinated the ACRr cells. A specific 230K membrane protein was found in the ACRr cells by immunoprecipitation. Natural BLM Resistance of Chinese Hamster V79 Cells: V79 cells were more resistant to BLM than CHO cells. This natural drug-resistance was is due to higher BLM hydrolase activity. We isolated BLM cell lines, and found that BLM supersensitivity was not due to BLM hydrolase, but to decreased repairing activity of DNA damage.
...
PMID:[Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic]. 621 60
Using partially purified mouse liver 23S mRNA known to be associated with the Ah locus and 3-methylcholanthrene-induced cytochrome P(1)-450, we synthesized double-stranded cDNA by the successive action of reverse transcriptase (RNA-directed
DNA nucleotidyltransferase
) and the Klenow A fragment of Escherichia coli
DNA polymerase I
. The double-stranded cDNA was inserted into pBR322 plasmid DNA by Pst I cleavage and homopolymeric "tailing" and cloned in E. coli LE392. Clone 46 hybridized with [(32)P]cDNA made from 23S mRNA from "Ah-responsive" C57BL/6N mice but did not hybridize with similarly prepared [(32)P]cDNA from "Ah-nonresponsive"
DBA
/2N mice. Clone 30 was positive, and clone 7 was negative, with both C57BL/6N and
DBA
/2N [(32)P]cDNA probes; these two clones were therefore used as "positive" and "negative" control clones, respectively. By translation-arrest experiments, clone 46 DNA and clone 30 DNA were shown to be associated with anti-P(1)-450- and anti-albumin-precipitable material, respectively. By agarose gel electrophoresis of Pst I digests, the clone 46 DNA insert was shown to be 1100 base pairs in total length and to contain one internal Pst I site. The cDNA made from total mRNA isolated from 3-methylcholanthrene-treated C57BL/6N mice hybridized to the two fragments of Pst I-digested DNA from clone 46, whereas similarly prepared cDNA from 3-methylcholanthrene-treated
DBA
/2N and control C57BL/6N and
DBA
/2N mice did not. Of 11 restriction endonucleases used, two (Pst I and Xba I) had sites within the clone 46 DNA insert. After hybridization of clone 46 (32)P-labeled nick-translated DNA to EcoRI fragments from A/HeJ mouse genomic DNA and fractionation by RPC-5 chromatography and gel electrophoresis, only one positive band (3-4 kilobase pairs appeared. These data demonstrate conclusively that pBR322 clone 46 DNA is associated with mRNA controlled by the murine Ah locus, presumably the structural gene encoding 3-methylcholanthrene-induced P(1)-450.
...
PMID:Isolation and characterization of a cloned DNA sequence associated with the murine Ah locus and a 3-methylcholanthrene-induced form of cytochrome P-450. 626 72
Cultures of murine Friend erythroleukemia (FL) cells, which are chronically infected with leukemia virus, were inoculated with vaccinia virus. The yield of vaccinia virus was determined by assaying plaque-forming units in mouse L2 cells, and the yield of leukemia virus was determined by measuring reverse transcriptase (RNA-dependent
DNA nucleotidyltransferase
) activity released into the culture fluid. Although no facilitation of one virus by the other was detected, persistently infected cultures were established. Electron microscopic examination revealed the presence of vaccinia and leukemia viruses in the same cell. The permanent lines of cells persistently infected with vaccinia were designated FLvac. Their morphology, growth rate, cloning efficiency, and ability to respond to the induction of erythrodifferentiation by treatment with dimethyl sulfoxide were not appreciably altered as compared to the parental FL cells. However, the persistently infected cells showed a marked decrease in tumorigenicity when assayed in
DBA
/2 mice. The infectious virus produced by FLvac cells and by L2 cells were indistinguishable as judged by restriction endonuclease patterns of virion DNA, structural proteins, and the activities of two virion-associated DNases. The yield of infectious vaccinia virus from FLvac cells generally declined after about 60 serial passages. Although some cell lines no longer yield infectious virus, they are resistant to challenge with vaccinia at concentrations that are cytolytic for L2 cells. The mechanism responsible for the establishment of the persistent infection remains unclear because defective particles, interferon production, and temperature-sensitive mutants have not been detected.
...
PMID:Persistent infection of Friend erythroleukemia cells with vaccinia virus. 695 93
Aphidicolin, an inhibitor of DNA polymerases alpha and delta, is cytotoxic in vitro against tumor cells. The poor solubility of aphidicolin has led to the development of aphidicolin glycinate (AG; NSC 303812), a water soluble ester currently in early clinical trials. The antitumor activity of AG was investigated in a series of transplantable murine tumors in vivo. The drug demonstrated activity against the i.p. implanted B16 melanoma, producing maximum increased life spans of 75% following i.p. administration every 3 h for three doses on days 1-9. Treatment schedules involving both single injections per day on days 1-9 and multiple injections per day on days 1, 5, and 9 were less effective, indicating that this antitumor activity is schedule dependent. Similarly, greater activity was observed against the i.p. M5076 sarcoma when three daily injections were given on days 1-9 (57% increased life span) than with a single injection either on days 1-9 (36% increased life span) or on days 1, 5, 9, and 13 (inactive). Further scheduling studies in the s.c. M5076 sarcoma model showed that a 7-day infusion was superior to both a 24-h infusion and a 7-day course of three bolus treatments per day. On the assumption that
DNA polymerase
inhibition is the basis for this antitumor activity, inhibition of DNA synthesis in BALB/c x
DBA
/2 F1 mice was investigated by measuring incorporation of [3H]thymidine (20 microCi, i.v.) into DNA of spleen and jejunum. At 2 h after administration of AG, inhibition of DNA synthesis was dose dependent (median inhibitory dose, 60 mg/kg in both tissues) and was > 99% at 300 mg/kg. The inhibition was rapid in onset; AG (100 mg/kg i.p.) produced maximal (> 98%) inhibition in both tissues at 30 min. Recovery occurred in the intestine within 16 h; in spleen recovery was delayed to 24 h, and was followed by a rebound incorporation at 48 h (203%). A comparison of the inhibition of thymidine incorporation in tumor cells (B16 melanoma and P388 leukemia) and normal jejunum revealed no significant differences in the extent of inhibition or the rapidity of recovery in these tissues. The rapid recovery of DNA synthesis inhibition supports the use of prolonged infusion schedules in clinical trials, but the lack of evidence of selectivity for tumor cells suggests that AG may be of limited therapeutic value as a single agent. Thus, we evaluated AG in combination with cisplatin in an in vivo model of cisplatin refractory human ovarian cancer.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. 830 34
Terminal deoxynucleotidyl transferase (TdT), a template-independent
DNA polymerase
, contributes to antigen receptor diversity in lymphocytes. Using in situ hybridization, we found that tdt is expressed within neurons of the adult mouse brain. tdt mRNA was localized within pyramidal neurons in the hippocampus, granule and polymorphic cells in the dentate gyrus, Purkinje neurons in the cerebellum, and cortical cells. Increased levels of tdt mRNA in the hippocampus, neocortex, and cerebellum were associated with rearing C57BL/6 mice, but not
DBA
/2 mice, in enriched environments. Unlike wild types (WT), tdt (-/-) mice did not show improvement in spatial learning and memory as a result of rearing in enriched environments. These results suggest that tdt may be involved in learning and memory saving.
...
PMID:Experience-dependent expression of terminal deoxynucleotidyl transferase in mouse brain. 1282 97